Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.

MLA

Maneix, Laure, et al. “Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.” Cancer Research Communications, vol. 2, no. 12, Dec. 2022, pp. 1693–710. EBSCOhost, https://doi.org/10.1158/2767-9764.crc-22-0255.

APA

Maneix, L., Iakova, P., Moree, S. E., Hsu, J. I., Mistry, R. M., Stossi, F., Lulla, P., Sun, Z., Sahin, E., Yellapragada, S. V., & Catic, A. (2022). Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation. Cancer Research Communications, 2(12), 1693–1710. https://doi.org/10.1158/2767-9764.crc-22-0255

Chicago

Maneix, Laure, Polina Iakova, Shannon E Moree, Joanne I Hsu, Ragini M Mistry, Fabio Stossi, Premal Lulla, et al. 2022. “Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.” Cancer Research Communications 2 (12): 1693–1710. doi:10.1158/2767-9764.crc-22-0255.